Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Double-blind, Active Control, Parallel, Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of CANIUM Tab. in Acute Bronchitis Patients.

NCT07835620 is registered in ClinicalTrials.gov with Dasan Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07835620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07835620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Double-blind, Active Control, Parallel, Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of CANIUM Tab. in Acute Bronchitis Patients.
Lead sponsor
Dasan Pharmaceutical Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
January 26, 2026
Completion date
September 9, 2026
Enrollment
223 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

acute bronchitis